Low endotoxin anti-bovine primary antibodies are purified to remove bacterial lipopolysaccharides (LPS), ensuring minimal immune activation. These ultra-pure reagents are specifically designed for sensitive applications such as live cell assays and in vivo studies, where endotoxin contamination can compromise experimental outcomes.

Endotoxin Effects

• LPS can activate immune cells at extremely low concentrations, leading to unintended responses.
• Conventional antibodies may contain endotoxin levels sufficient to induce experimental artifacts.
• Low endotoxin formulations remain below activation thresholds, preserving biological accuracy.

Purification and Properties

• Advanced chromatography and filtration remove endotoxin while maintaining antibody integrity.
• Supplied carrier-free in PBS, ensuring compatibility with downstream applications.
• Low aggregation minimizes non-specific binding and improves reproducibility.

Applications

• Functional assays, neutralization studies, and primary bovine cell culture.
• In vivo experiments requiring minimal inflammatory interference.
• Flow cytometry without endotoxin-induced activation artifacts.